FDA approves aflibercept injection for macular edema following central retinal vein occlusion
September 24th 2012FDA has approved aflibercept (Eylea, Regeneron) injection for the treatment of macular edema following central retinal vein occlusion (CRVO). The recommended dose for Eylea is 2 mg every 4 weeks (monthly).
New guidelines: Screen adults for hypertriglyceridemia every 5 years
September 20th 2012An Endocrine Society task force has established new clinical-practice guidelines that recommend screening adults for high triglyceride levels. Find out the reason behind the new recommendations and how often the screening should be administered.
PBM practices hurt patients and community pharmacists, NCPA says
September 19th 2012Most community pharmacists - about 87% - believe that PBM reimbursement and auditing practices are affecting their ability to provide patient care and stay in business, according to a National Community Pharmacists Association survey.
Mentors, peer review, and the oath of a pharmacist
September 15th 2012Professions survive and prosper when mentors and their juniors embrace one another respectfully and cooperatively for the progressive promotion of their vocation. In this way, the seniors would not carry their valuable professional experience to their graves, and the juniors would not commit irreparable blunders as they enter the stage of practice.
tPA: Still the underused clot-buster in stroke management
September 15th 2012Patients suffering stroke often do not seek immediate help. Just as disturbing, lack of stroke expertise in many hospitals and skepticism among ER physicians may prevent tPA from being administered to the patients who need it most.